Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8d0fc2b70675ee19bd5fc464f5ae9061 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2533-80 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2533-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2533-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N1-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-532 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0693 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6863 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12M23-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12M3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5011 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-532 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12M3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N1-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate |
2015-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5101a19e40f03cc47f46aa9956c2c19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f30d12ff62062d47f6ae0e819d755ca4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_809328a8642792119dafcd393c585ccf |
publicationDate |
2017-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20170074503-A |
titleOfInvention |
Drug test method for using cell culture assay |
abstract |
A method for evaluating a drug using a cell culture assay is provided. A method for evaluating a drug using a three-dimensional cell culture assay comprising a plurality of units according to an embodiment of the present invention includes the steps of (a) mixing cells isolated from a patient's tissue with different extracellular matrix gels And (b) evaluating the survival rate of the cells as the culture medium is supplied to cells mixed with the extracellular matrix gel, for each of the units, and c) determining cell culture conditions including information of the extracellular matrix gel and the culture medium injected into the unit having the highest survival rate of the cells. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200079029-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019050101-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20210070537-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021112638-A1 |
priorityDate |
2015-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |